Targeted delivery of doxorubicin: Drug delivery system based on PAMAM dendrimers

Yabbarov N.G., Posypanova G.A., Vorontsov E.A., Popova O.N., Severin E.S.
Тип документаJournal Article
Дата публикации2013-08-15
Название журналаBiochemistry (Moscow)
ИздательPleiades Publishing
Квартиль по SCImagoQ2
Квартиль по Web of ScienceQ4
Импакт-фактор 20212.82
ISSN00062979, 16083040
Biochemistry
General Medicine
Краткое описание
Polyamidoamine (PAMAM) dendrimers of the second generation (G2) are branched polymers containing 16 surface amino groups that allow them to be used as universal carriers on creating systems for drug delivery. G2 labeled with fluorescein isothiocyanate (FITC) efficiently bound with the surface of tumor cells at 4°C and was absorbed by the cells at 37°C. The covalent binding to G2-FITC of a vector protein, a recombinant fragment of the human alpha-fetoprotein receptor-binding domain (rAFP3D), increased the binding and endocytosis efficiency more than threefold. Covalent conjugates of G2 with doxorubicin (Dox) obtained by acid-labile linking of cis-aconitic anhydride (CAA) without the vector protein (G2-Dox) and with the vector protein rAFP3D (rAFP3D-G2-Dox) were accumulated by the tumor cells with high efficiency. However, a selective effect was observed only in rAFP3D-G2-Dox, which also demonstrated high cytotoxic activity against the human ovarian adenocarcinoma SKOV3 cells and low cytotoxicity against human peripheral blood lymphocytes. Based on these results, rAFP3D-G2 conjugate is promising for selective delivery of antitumor drugs.
Пристатейные ссылки: 33
Цитируется в публикациях: 22
Monoclonal antibody therapy for malignant glioma.
Chen K.S., Mitchell D.A.
Q2 Advances in Experimental Medicine and Biology 2012 цитирований: 18
Open Access
Open access
Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma.
Ward B.B., Dunham T., Majoros I.J., Baker J.R.
Q1 Journal of Oral and Maxillofacial Surgery 2011 цитирований: 25
Efficient refolding of a hydrophobic protein with multiple S-S bonds by on-resin immobilized metal affinity chromatography.
Sharapova O.A., Yurkova M.S., Laurinavichyute D.K., Andronova S.M., Fedorov A.N., Severin S.E., Severin E.S.
Q1 Journal of Chromatography A 2011 цитирований: 11
Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in HER2-positive cancer cells.
Miyano T., Wijagkanalan W., Kawakami S., Yamashita F., Hashida M.
Q1 Molecular Pharmaceutics 2010 цитирований: 46
Dendrimer internalization and intracellular trafficking in living cells.
Albertazzi L., Serresi M., Albanese A., Beltram F.
Q1 Molecular Pharmaceutics 2010 цитирований: 145
The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway.
Qi R., Mullen D.G., Baker J.R., Banaszak Holl M.M.
Q1 Molecular Pharmaceutics 2010 цитирований: 33
Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
Saovapakhiran A., D’Emanuele A., Attwood D., Penny J.
Q1 Bioconjugate Chemistry 2009 цитирований: 93
The effect of surface functionality on cellular trafficking of dendrimers.
Perumal O.P., Inapagolla R., Kannan S., Kannan R.M.
Q1 Biomaterials 2008 цитирований: 270
Open Access
Open access
Ligand based dendritic systems for tumor targeting.
Agarwal A., Saraf S., Asthana A., Gupta U., Gajbhiye V., Jain N.K.
Q1 International Journal of Pharmaceutics 2008 цитирований: 84
Open Access
Open access
Recombinant alpha-fetoprotein C-terminal fragment: The new recombinant vector for targeted delivery
Posypanova G.A., Gorokhovets N.V., Makarov V.A., Savvateeva L.V., Kireeva N.N., Severin S.E., Severin E.S.
Q1 Journal of Drug Targeting 2008 цитирований: 24
Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells.
Kitchens K.M., Kolhatkar R.B., Swaan P.W., Ghandehari H.
Q1 Molecular Pharmaceutics 2008 цитирований: 122
Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells
Kitchens K.M., Foraker A.B., Kolhatkar R.B., Swaan P.W., Ghandehari H.
Q2 Pharmaceutical Research 2007 цитирований: 143
Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers.
Tian Y., Bromberg L., Lin S.N., Alan Hatton T., Tam K.C.
Q1 Journal of Controlled Release 2007 цитирований: 134
Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells.
Seib F.P., Jones A.T., Duncan R.
Q1 Journal of Controlled Release 2007 цитирований: 155
Dendrimers in biomedical applications--reflections on the field.
SVENSON S., TOMALIA D.
Q1 Advanced Drug Delivery Reviews 2005 цитирований: 1265
Метрики
Поделиться
Цитировать
ГОСТ |
Цитировать
1. Yabbarov N. G. и др. Targeted delivery of doxorubicin: Drug delivery system based on PAMAM dendrimers // Biochemistry (Moscow). 2013. Т. 78. № 8. С. 884–894.
RIS |
Цитировать

TY - JOUR

DO - 10.1134/s000629791308004x

UR - http://dx.doi.org/10.1134/s000629791308004x

TI - Targeted delivery of doxorubicin: Drug delivery system based on PAMAM dendrimers

T2 - Biochemistry (Moscow)

AU - Yabbarov, N. G.

AU - Posypanova, G. A.

AU - Vorontsov, E. A.

AU - Popova, O. N.

AU - Severin, E. S.

PY - 2013

DA - 2013/08

PB - Pleiades Publishing Ltd

SP - 884-894

IS - 8

VL - 78

SN - 0006-2979

SN - 1608-3040

ER -

BibTex |
Цитировать

@article{Yabbarov_2013,

doi = {10.1134/s000629791308004x},

url = {https://doi.org/10.1134%2Fs000629791308004x},

year = 2013,

month = {aug},

publisher = {Pleiades Publishing Ltd},

volume = {78},

number = {8},

pages = {884--894},

author = {N. G. Yabbarov and G. A. Posypanova and E. A. Vorontsov and O. N. Popova and E. S. Severin},

title = {Targeted delivery of doxorubicin: Drug delivery system based on {PAMAM} dendrimers},

journal = {Biochemistry (Moscow)}

}

MLA
Цитировать
Yabbarov, N. G., et al. “Targeted Delivery of Doxorubicin: Drug Delivery System Based on PAMAM Dendrimers.” Biochemistry (Moscow), vol. 78, no. 8, Aug. 2013, pp. 884–94. Crossref, https://doi.org/10.1134/s000629791308004x.